JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 17, 2004; DOI: 10.1124/jpet.104.071324


0022-3565/04/3113-921-928$20.00
JPET 311:921-928, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.071324v1
311/3/921    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uesugi, T.
Right arrow Articles by Arteel, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uesugi, T.
Right arrow Articles by Arteel, G. E.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Contribution of Angiotensin II to Alcohol-Induced Pancreatic Fibrosis in Rats

Takehiko Uesugi, Matthias Froh, Erwin Gäbele, Fuyumi Isayama, Blair U. Bradford, Iwao Ikai, Yoshio Yamaoka, and Gavin E. Arteel

Laboratory of Hepatobiology and Toxicology, Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (T.U., M.F., E.G., F.I., B.U.B., G.E.A.); Department of Gastroenterological Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan (T.U., I.I., Y.Y.); and Department of Pharmacology and Toxicology and the James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky (G.E.A.)

The mechanisms by which alcohol causes pancreatic fibrosis remain unknown. Recent studies have demonstrated that angiotensin II contributes to the development of fibrosis in liver, kidney, and heart injury. Here, the effects of angiotensin-converting enzyme inhibitor (captopril) and angiotensin II receptor antagonist (losartan) on alcohol-induced pancreatic fibrosis were examined in an intragastric ethanol-feeding model. Male rats were fed a high-fat liquid diet with either ethanol (16–20 g/kg/day) or isocaloric maltose-dextrin (control) for 4 weeks. Subgroups daily received captopril (60 mg/kg/day), losartan (3 mg/kg/day), or no additional agent included in liquid diets. Mean urine alcohol concentrations in all groups fed ethanol were more than 270 mg/dl and not significantly different. Dietary alcohol caused diffuse gland atrophy and interlobular and intralobular fibrosis with mild structural distortion in the pancreas, an effect that was blunted by captopril or losartan treatment. Alcohol also increased the number of {alpha}-smooth muscle actin-positive cells and transforming growth factor-{beta} mRNA expression in the pancreas. These increases were blunted significantly by captopril or losartan treatment. These data suggest that angiotensin II contributes to the development of chronic alcohol-induced pancreatic fibrosis through its stimulation of transforming growth factor-{beta} expression.


Received May 12, 2004; accepted August 16, 2004.

Address correspondence to: Dr. Gavin E. Arteel, Department of Pharmacology and Toxicology, 1307 Research Tower, HSC, University of Louisville School of Medicine, Louisville, KY 40292. E-mail: gavin.arteel{at}louisville.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.